We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Researchers Create Novel DNA-Repair Enzyme

By Biotechdaily staff writers
Posted on 23 May 2002
Data from the Human Genome Project has been used by scientists to synthesize a human DNA repair enzyme. More...
The human genome was scanned to find sequences similar to those known to code for DNA repair enzymes, known as glycosylases, in E coli bacteria.

After identifying two such sequences, researchers from the University of Texas Medical Branch (Galveston, USA; www.utmb.edu) and colleagues from other institutions then used one of them to produce a previously unknown protein, which proved able to function as a glycosylase when tested on damaged DNA in vitro. This glycosylase, which they named NEH1, is the first to be discovered of a new class of mammalian DNA repair enzymes. This research was reported in the March 19, 2002 issue of the Proceedings of the National Academy of Sciences.

NEHI possesses two characteristics that enhance its effectiveness in repairing oxidative damage. First, NEH1 may work on the small, critical portion of human DNA that is actually active. Second, cells produce far more NEH1 when their DNA is replicating, as if to catch any errors introduced by oxidative stress before they are passed on to the next generation.

"This replication coupling is fascinating,” Mitra says, "and so is the way in which the repair of active genes is different from the repair of the bulk of the genome.” The researchers also examined human tissues for NEH1, seeking to determine its relative level in different organs of the body. They found that messenger RNA coding for NEH1 was highest in the liver, pancreas and thymus.




Related Links:
University of Texas Medical Branch

New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Urine Analyzer
respons® UDS100
New
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Study results show blood protein levels change markedly in childhood and adolescence, with sex differences increasing with age (photo credit: Adobe Stock)

Proteomic Data Underscore Need for Age-Specific Pediatric Reference Ranges

Serum proteins underpin many routine tests used to detect inflammation, hormonal imbalance, cardiovascular disease, and metabolic disorders. Yet pediatric interpretation often relies on adult reference... Read more

Pathology

view channel
Image: Study flowchart. This study developed a multimodal artificial intelligence framework to predict PIK3CA mutations in breast cancer (Jiaxian Miao et al., Cancer Biol Med 23(3): 430–450 (2026). DOI: 10.20892/j.issn.2095-3941.2025.0771)

Multimodal AI Tool Predicts Genetic Alterations to Guide Breast Cancer Treatment

PIK3CA mutations are key biomarkers for selecting phosphoinositide 3-kinase (PI3K)–targeted therapies in breast cancer, yet access to molecular testing can be inconsistent and costly. Conventional polymerase... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.